1. Home
  2. GDDY vs PTGX Comparison

GDDY vs PTGX Comparison

Compare GDDY & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoDaddy Inc.

GDDY

GoDaddy Inc.

HOLD

Current Price

$96.71

Market Cap

11.0B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$138.70

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDDY
PTGX
Founded
1997
2006
Country
United States
United States
Employees
N/A
141
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
9.3B
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
GDDY
PTGX
Price
$96.71
$138.70
Analyst Decision
Buy
Strong Buy
Analyst Count
16
13
Target Price
$136.44
$108.23
AVG Volume (30 Days)
1.8M
498.6K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.43
2.35
Revenue
N/A
N/A
Revenue This Year
$7.94
$874.25
Revenue Next Year
$6.10
N/A
P/E Ratio
$28.64
$61.73
Revenue Growth
N/A
N/A
52 Week Low
$71.59
$62.24
52 Week High
$143.34
$160.81

Technical Indicators

Market Signals
Indicator
GDDY
PTGX
Relative Strength Index (RSI) N/A 49.01
Support Level N/A $141.95
Resistance Level N/A $151.24
Average True Range (ATR) 0.00 4.49
MACD 0.00 -0.52
Stochastic Oscillator 0.00 42.25

Price Performance

Historical Comparison
GDDY
PTGX

About GDDY GoDaddy Inc.

GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: